CELL — Cellularline SpA Income Statement
0.000.00%
Last trade - 00:00
- €59.33m
- €82.72m
- €158.65m
- 69
- 84
- 57
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 140 | 105 | 111 | 138 | 159 |
Cost of Revenue | |||||
Gross Profit | 64.6 | 44.9 | 48.2 | 48.8 | 61.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 120 | 108 | 116 | 214 | 154 |
Operating Profit | 20.3 | -3.4 | -5.16 | -76.3 | 4.88 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 20.1 | -2.4 | -6.56 | -74.8 | 4.25 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18.2 | 13.9 | -3.85 | -75.2 | 3.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 18.2 | 13.9 | -3.85 | -75.2 | 3.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18.2 | 13.9 | -3.85 | -75.2 | 3.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.849 | 0.867 | 0.101 | -1.14 | 0.263 |
Dividends per Share |